Hardman Johnston Global Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AAMU
FMI
DSA
Hardman Johnston Global Advisors's DGX Position: Q2 2019 in Review
Hardman Johnston Global Advisors sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 181,359 shares — an estimated $16.3M sold.
Hardman Johnston Global Advisors first reported a position in DGX in Q2 2013 and held it in 24 quarters. The position peaked at $21.9M in Q2 2017. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.
- Hardman Johnston Global Advisors reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
- Hardman Johnston Global Advisors sold 181,359 Quest Diagnostics shares in Q2 2019, an estimated $16.3M.
- Hardman Johnston Global Advisors first reported a position in Quest Diagnostics in Q2 2013 and held it in 24 quarters.
- Hardman Johnston Global Advisors's Quest Diagnostics position peaked at $21.9M in Q2 2017.
- 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.
Based on Hardman Johnston Global Advisors's 13F filing for Q2 2019, filed 5 Aug 2019.